• Fri, February 24, 2023

Yigal Nochomovitz Maintained (CALT) at Strong Buy with Increased Target to $79 on, Feb 24th, 2023

Yigal Nochomovitz of Citigroup, Maintained "Calliditas Therapeutics AB (publ)" (CALT) at Strong Buy with Increased Target from $76 to $79 on, Feb 24th, 2023.

Yigal, nor any peers, have made any analyst calls on CALT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍